Pilot project for the implementation of a screening tool to improve the prevention, diagnosis, and treatment of patients with a neurodevelopmental psychiatric disorder: Using the 22q11.2 deletion syndrome (22q11.2DS) as a model

Double-blind randomized controlled pilot study of the efficacy of nutraceuticals combined with physical activity as an adjunctive treatment for autism and schizophrenia.

Contribution of mitochondrial DNA in early psychoses: relationship with disease risk, stress, cognitive performance, clinical symptoms and metabolic syndrome

Mitochondrial DNA mutations contribute to autism and also to the characteristics of mitochondrial disorders present in patients with autism spectrum disorders

Double blind, placebo-controlled study of efficacy, safety and tolerance of raloxifene as an adjuvant treatment for negative symptoms of schizophrenia in postmenopausal women